| 6.41 Data as of 4:00pm ET |  -0.02 / -0.31%Today’s Change | 4.25 Today|||52-Week Range 6.56 | +29.49% Year-to-Date |
| PBTH July Options Begin Trading May 20 / TheStreet.com |
| Previous close | 6.43 |
| Today’s open | 6.38 |
| Day’s range | 6.36 - 6.46 |
| Volume | 100,104 |
| Average volume (3 months) | 281,492 |
| Market cap | $409.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -3.45% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.28 |
| Today’s change | Today’s % change | |
|---|---|---|
| FURXFuriex Pharmaceutica... | +0.37 | +0.94% |
| NLNKNewLink Genetics Cor... | +0.50 | +3.22% |
| GTXIGTX Inc | +0.18 | +2.86% |
| INSMInsmed Inc | 0.00 | 0.00% |
| Next reporting date | May 29, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Abraham Havron, PhD |
President & Director Shai A. Novik, MBA |
Corporate headquarters Nes Ziona, -- |
.
